307
Participants
Start Date
August 31, 2004
Primary Completion Date
December 31, 2005
Study Completion Date
August 31, 2006
Tolterodine
4mg/d for 10 weeks. Could be reduced to 2mg/d for managing side effects.
Behavioral training
Training in pelvic floor muscle control and exercises; behavioral strategies to diminish urgency, suppress bladder contractions and prevent incontinence; delayed voiding; and individualized fluid management.
University of Pittsburgh, Pittsburgh
University of Maryland, Baltimore
University of Alabama, Birmingham
Oakwood Hospital and Medical Center, Royal Oak
Loyola University Medical Center, Maywood
University of Texas Southwestern, Dallas
University of Texas Health Sciences Center, San Antonio
University of Utah, Salt Lake City
University of California, San Diego
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Carelon Research
OTHER